HomePublication List

Publication List

 

2019

154.
Hashimoto, S., S. Furukawa, A. Hashimoto, A. Tsutaho, A. Fukao, Y. Sakamura, G. Parajuli, Y. Onodera, Y. Otsuka, H. Handa, T. Oikawa, S. Hata, Y. Nishikawa, Y. Mizukami, Y. Kodama, M. Murakami, T. Fujiwara, S. Hirano, and H. Sabe. ARF6 and AMAP1 are major targets of KRAS and TP53 mutations to promote invasion, PD-L1 dynamics, and immune evasion of pancreatic cancer. PNAS 2019 Aug 9. pii: 201901765. doi: 10.1073/pnas.1901765116. (PubMed)
153.
Stofkova, A., and M. Murakami. Neural activity regulates autoimmune diseases through the gateway reflex. Bioelectric Med. 5, Article number: 14 (Bioelect Med.) (Review)
152.
Nishida, K., A. Hasegawa A, S. Yamasaki, R. Uchida, W. Ohashi, Y. Kurashima, J. Kunisawa, S. Kimura, T. Iwanaga, H. Watarai, K. Hase, H. Ogura, M. Nakayama, JI Kashiwakura, Y. Okayama, M. Kubo, O. Ohara, H. Kiyono, H. Koseki, M. Murakami, and T. Hirano. Mast cells play role in wound healing through the ZnT2/GPR39/IL-6 axis. Sci Rep. 2019 Jul 25;9(1):10842. doi: 10.1038/s41598-019-47132-5. (PubMed)
151.
Tanaka, H., Y. Arima, D. Kamimura, Y. Tanaka, N. Takahashi, T. Uehata, K. Maeda, T. Satoh, M. Murakami, and S. Akira. Phosphorylation-dependent Regnase-1 release from endoplasmic reticulum is critical in IL-17 response. J Exp Med. Jun 3;216(6):1431-1449. doi: 10.1084/jem.20181078.(PubMed)
150.
Murakami, M., D. Kamimura and T. Hirano. Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines. Immunity. 50(4), 812-831, 2019. doi: 10.1016/j.immuni.2019.03.027. (PubMed) (Review)
149.
Kamimura, D., and M. Murakami. Neural stimulations regulate the infiltration of immune cells into the CNS. J Intern Med. Sep;286(3):259-267. doi: 10.1111/joim.12912, 2019 (PubMed) (Review)
148.
Stofkova, A., D. Kamimura, T. Ohki, M. Ota, Y. Arima, and M. Murakami. Photopic light-mediated down-regulation of local α1A-adrenergic signaling protects blood-retina barrier in experimental autoimmune uveoretinitis. Sci Rep. 9, Article number: 2353, 2019. (PubMed)
147.
Fujita, M., Y. Yamamoto, J-J. Jiang, T. Atsumi, Y. Tanaka, T. Ohki, N. Murao, E. Funayama, T. Hayashi, M. Osawa, T. Maeda, D. Kamimura, and M. Murakami. NEDD4 is involved in inflammation development during keloid formation. J Invest Dermatol. 139, 333-341, 2019. (PubMed) (Commentary in JID)

 

2018

146.
Kamimura, D., T. Ohki, Y. Arima, M. Ota and M. Murakami. Gateway reflex: Local neuroimmune interactions that regulate blood vessels. Neurochem Int. Sep 29:104303. doi: 10.1016/j.neuint.2018.09.011. (PubMed) (Review)
145.
Tanaka, Y.*, L. Sabharwal* (Equal contribution), M. Ota, I. Nakagawa, J-J. Jiang, Y. Arima, H. Ogura, M. Okochi,  M. Ishii, D. Kamimura# and M. Murakami# (#Corresponding authors). Presenilin 1 regulates NF-κB activation via association with breakpoint cluster region and casein kinase II. J Immunol. Oct 15;201(8):2256-2263, 2018. doi: 10.4049/jimmunol.1701446. (PubMed)
144.
Okuyama, Y.*, Y. Tanaka*, J-J. Jiang*, D. Kamimura*# (*Equal contribution, #Corresponding authors), A. Nakamura, M. Ota, T. Ohki, D. Higo, H. Ogura, N. Ishii, T. Atsumi and M. Murakami#. Bmi1 regulates IkBa degradation via association with the SCF complex. J Immunol. Oct 15;201(8):2264-2272, 2018. doi: 10.4049/jimmunol.1701223. (PubMed)
143.
Kamimura, D., T. Ohki, Y. Arima, and M. Murakami. Gateway reflex: neural activation-mediated immune cell gateways in the central nervous system. Int Immunol. 30(7), 281-289, 2018 May 15. doi: 10.1093/intimm/dxy034. (PubMed) (Review)
142.
Tainaka, K., TC. Murakami, EA. Susaki, C. Shimizu, R. Saito, K. Takahash, A. Hayashi-Takagi, H. Sekiya, Y. Arima, S. Nojima, M. Ikemura, T. Ushiku, Y. Shimizu, M. Murakami, KF. Tanaka, M. Iino, H. Kasai, T. Sasaoka, K. Kobayashi, K. Miyazono, E. Morii, T. Isa, M. Fukayama, A. Kakita, and HR. Ueda. Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents. Cell Rep. 2018 Aug 21;24(8):2196-2210.e9. doi: 10.1016/j.celrep.2018.07.056. (PubMed)
141.
Itabashi, T., Y. Arima, D. Kamimura, K. Higuchi, Y. Bando, H. Takahashi-Iwanaga, M. Murakami, M. Watanabe, and T. Iwanaga. Cell- and stage-specific localization of galectin-3, a beta-galactoside-binding lectin, in a mouse model of experimental autoimmune encephalomyelitis. Neurochem Int. 118: 176-184, 2018. doi: 10.1016/j.neuint.2018.06.007. (PubMed)
140.
Kijimoto-Ochiai, S., T. M-Mizuno, D. Kamimura, M. Murakami, M. Kobayashi, I Matsuoka, H. Ochiai, H. Ishida, M. Kiso, K. Kamimura, and T. Koda. Existence of NEU1 sialidase on mouse thymocytes whose natural substrate is CD5. Glycobiology 28(5): 306-317, 2018 doi: 10.1093/glycob/cwy009 (Glycobiology)

2017

139.
Atsumi, T.*, H. Suzuki*, J-J. Jiang* (* equal contribution), Y. Okuyama, I. Nakagawa, M. Ota, Y. Tanaka, T. Ohki, K. Katsunuma, K. Nakajima, Y. Hasegawa, O. Ohara, H. Ogura, Y. Arima, D. Kamimura, and M. Murakami. Rbm10 regulates inflammation development via alternative splicing of Dnmt3b. Int Immunol. 29(12):581-591, 2017. doi: 10.1093/intimm/dxx067. (PubMed)
138.
Tanaka, T., Y. Arima, D. Kamimura, and M. Murakami. The gateway reflex, a novel neuro-immune interaction for the regulation of regional vessels. Front Immunol. Oct 18;8:1321, doi: 10.3389/fimmu.2017.01321. 2017. (PubMed)
137.
Arima, Y.*, T. Ohki*, N. Nishikawa*, K. Higuchi* (* equal contribution), M. Ota, Y. Tanaka, J. Nio-Kobayashi, M. Elfeky, R. Sakai, Y. Mori, T. Kawamoto, A. Stofkova, Y. Sakashita, Y. Morimoto, M. Kuwatani, T. Iwanaga, Y. Yoshioka, N. Sakamoto, A. Yoshimura, M. Takiguchi, S. Sakoda, M. Prinz, D. Kamimura, M. Murakami. Brain micro-inflammation at specific vessels dysregulates organ-homeostasis via the activation of a new neural circuit. eLife 6:e25517 DOI: 10.7554/eLife.25517, 2017 (eLife)
136.
Elfeky, M., D. Kamimura, Y. Arima, M. Murakami and L. Steinman. Targeting molecules involved in immune cell trafficking to the central nervous system for therapy in multiple sclerosis. Clin Exp Neuroimmunol. 8(3), 183-191, 2017 (CENI) (Review)
135.
Tanaka, Y., Y. Arima, K. Higuchi, T. Ohki, M. Elfeky, M. Ota, D. Kamimura and M. Murakami. EAE Induction by Passive Transfer of MOG-specific CD4+ T Cells. Bio-protocol. 7(13), 7/5/2017, DOI: https://doi.org/10.21769/BioProtoc.2370, 2017 (Bio-Protocol)
134.
Kitada, S. H. Kayama, D. Okuzaki, R. Koga, M. Kobayashi, Y. Arima, A. Kumanogoh, M. Murakami, M. Ikawa, K. Takeda. BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection. J. Exp. Med. 214(5):1313-1331, 2017 (PubMed)
133.
Murakami, M. Recent advances in neuroimmune interactions. Clin Exp Neuroimmunol. 8: 3-4, 2017 (CEN) (Editorial)
132.
Ohki, T., D. Kamimura, Y. Arima, M. Murakami. Gateway reflex, a new paradigm of neuro-immune interaction. Clin Exp Neuroimmunol. 8: 23-32, 2017 (CEN) (Review)
131.
Higuchi, K., D. Kamimura, A. Stofkova, N. Nishikawa, T. Ohki, Y. Arima, M. Murakami. Gateway reflexes are stimulated by neural activations and promote the pathogenesis of multiple sclerosis models. Nutrition and Lifestyle in Neurological Autoimmune Diseases. Chapter 5, 39-45, 2017 (Elsevier) (Review)

2016

130.
Meng, J.*, J-J Jiang* (*Equal contribution), T. Atsumi, H. Bando, Y. Okuyama, L. Sabharwal, I. Nakagawa, H. Higuchi, M. Ota, M. Okawara, R. Ishitani, O. Nureki, D. Higo, Y. Arima, H. Ogura, D. Kamimura and M. Murakami. Breakpoint cluster region-mediated inflammation is dependent on casein kinase II. J Immunol 197(8), 3111-3119, 2016 (PubMed)
129.
Ota, M., D. Kamimura, I. Nakagawa, H. Higuchi, Y. Tanaka, M. Fujita, S. Hiratsuka, M. Okawara, K. Murakami, T. Atsumi, Y. Arima and M. Murakami. Control of chronic inflammation by the inflammation amplifier and gateway reflexes. Advances in Medicine and Biology 104: Chapter 4, 65-86, 2016 (Review) (NOVA)
128.
Kamimura, D. Y. Arima, M. Tsuruoka, J-J Jiang, H. Bando, J. Meng, L. Sabharwal, A. Stofkova, N. Nishikawa, K. Higuchi, H. Ogura, T. Atsumi, M. Murakami. Strong TCR-mediated signals suppress integrated stress responses induced by KDELR1 deficiency in naïve T cells. Int Immunol. 28(3), 117-126, 2016. doi: 10.1093/intimm/dxv059 (PubMed) (Featured article in Int Immunol)

2015

127.
Nakagawa, I., D. Kamimura, T. Atsumi, Y. Arima, M. Murakami. Role of inflammation amplifier-induced growth factor expression in the development of inflammatory diseases. Crit Rev Immunol. 35(5), 365-78, 2015 (Review)
126.
Kamimura, D., T. Atsumi, A. Stofkova, N. Nishikawa, T. Ohki, H. Suzuki, K. Katsunuma, J-J Jiang, H. Bando, J. Meng, L. Sabharwal, H. Ogura, T. Hirano, Y. Arima, M. Murakami. Naive T cell homeostasis regulated by stress responses and TCR signaling. Front Immunol 6, Article 638, 2015 doi: 10.3389/fimmu.2015.00638 (Review)
125.
Nakanishi, K., M. Nishida1, M. Harada, T. Ohama, N. Kawada, M. Murakami, T. Moriyama1, K. Yamauchi-Takihara. Klotho-related molecules upregulated by smoking habit in apparently healthy men: A crosssectional study. Sci Rep. 5: 14230, 2015 (Sci Rep)
124.
Arima, Y., K. Higuchi, N. Nishikawa, A. Stofkova, T Ohki, D. Kamimura, M. Murakami. Pain is an inducer for relapse in multiple sclerosis models via a regional neural signal. Clin Exp Neuroimmunol. 6, 343-344, 2015 DOI: 10.1111/cen3.12250 (Review) (CEN)
123.
Kamimura, D., Y. Arima, T. Atsumi, J. Meng, L. Sabharwal, H. Bando, J-J. Jiang, ES. Huseby, M. Murakami. Role of cytokine-mediated crosstalk between T cells and nonimmune cells in the pathophysiology of multiple sclerosis. Chapter 6 in Multiple Sclerosis (Elsevier) 2015. (Review)
122.
Arima, Y*., D. Kamimura* (*Equal contribution), T. Atsumi, M. Harada, T. Kawamoto, N. Nishikawa, A. Stofkova1, T. Ohki, K. Higuchi, Y. Morimoto, P. Wieghofer, Y. Okada, Y. Mori, S. Sakoda, S. Saika, Y. Yoshioka, I. Komuro, T. Yamashita, T. Hirano, M. Prinz, M. Murakami. A pain-mediated neural signal induces relapse in multiple sclerosis models. eLife 4: e08733, 2015 doi: 10.7554/eLife.08733. (eLife)
121.
Huseby, ES., D. Kamimura, Y. Arima, CS. Parello, K. Sasaki, M. Murakami. Role of T cell – glial cell interactions in creating and amplifying Central Nervous System inflammation and Multiple Sclerosis disease symptoms. Frontiers in Cellular Neuroscience. 9, Article 295, 2015 doi: 10.3389/fncel.2015.00295. (Review) (PubMed)
120.
Ito, D., S. Nojima, M. Nishide, T. Okuno, H. Takamatsu, S. Kang, T. Kimura, Y. Yoshida, K. Morimoto, Y. Maeda, T. Hosokawa, T. Toyofuku, J. Ohshima, D. Kamimura, M. Yamamoto, M. Murakami, E. Morii, H. Rakugi, Y. Isaka, A. Kumanogoh. mTOR complex signaling through the SEMA4A-Plexin B2 axis is required for optimal activation and differentiation of CD8+ T cells. J Immunol. 195(3):934-43, 2015 (PubMed)
119.
Hashimoto-Kataoka, T., N. Hosen, T. Sonobe, Y. Arita, T. Yasui, T. Masaki, M. Minami, T. Inagaki, S. Miyagawa, Y. Sawa, M. Murakami, A. Kumanogoh, K. Yamauchi-Takihara, M. Okumura, T. Kishimoto, I. Komuro, M. Shirai, Y. Sakata, Y. Nakaoka. Interleukin-6/interleukin-21 signaling axis is critical in the pathogenesis of pulmonary arterial hypertension. Proc Natl Acad Sci USA. 2015 May 19;112(20):E2677-86. (PubMed)
118.
Kamimura, D.*#, K. Katsunuma*, Y. Arima, T. Atsumi, J-J Jiang, H. Bando, J. Meng, L. Sabharwal, A. Stofkova, N. Nishikawa, H. Suzuki, H. Ogura, N. Ueda, M. Tsuruoka, M. Harada, J. Kobayashi, T. Hasegawa, H. Yoshida, H. Koseki, I. Miura, S. Wakana, K. Nishida, H. Kitamura, T. Fukada, T. Hirano, and M. Murakami#. (*Equal contribution, #Equal correspondence), KDEL receptor 1 regulates T-cell homeostasis via PP1 that is a key phosphatase for ISR. Nat. Commun. 6, Article number: 7474, doi:10.1038/ncomms8474, 2015 (Nat Commun.)
117.
Maeda, K., T. Kosugi, W. Sato, H. Kojima, Y. Sato, D. Kamimura, N. Kato, N. Tsuboi, Y. Yuzawa, S. Matsuo, M. Murakami, S. Maruyama, K. Kadomatsu. CD147/Basigin limits lupus nephritis and TH17 cell differentiation by inhibiting the IL-6/STAT3 pathway. Arthritis Rheumatol. 6(2):120–128, 2015. (A&R)
116.
Kamimura, D., A. Stofkova, N. Nishikawa, T. Atsumi, Y. Arima, M. Murakami. Immune Cell Gateways in the CNS Regulated by Regional Neural Stimulations. Clin Exp Neuroimmunol. 6(2):120–128, 2015. DOI: 10.1111/cen3.12198 (Review) (CEN)
115.
Harada, M.*, D. Kamimura* (*, equal contribution),Y. Arima, H. Kohsaka, Y. Nakatsuji, M. Nishida, T. Atsumi, J. Meng, H. Bando, Sngh, L. Sabharwal, J-J. Jiang, N. Kumai, N. Miyasaka, S. Sakoda, K. Yamauchi-Takihara, H. Ogura, T. Hirano and M. Murakami. Temporal Expression of Growth Factors Triggered by Epiregulin Regulates Inflammation Development. J. Immunol. 194(3):1039-46, 2015 (PubMed)

2014

114.
Sabharwal, L.*, D. Kamimura* (*, equal contribution), J. Meng, H. Bando, H. Ogura, C. Nakayama, J-J. Jiang, N. Kumai, H. Suzuki, T. Atsumi, Y. Arima and M. Murakami. The Gateway Reflex, which is mediated by the inflammation amplifier, directs pathogenic immune cells into the CNS. J. Biochem. 156(6):299-304, 2014 (PubMed) (Review)
113.
Hojyo S., T. Miyai, H. Fujishiro, M. Kawamura, T. Yasuda, A. Hijikata, B-H Bin, T. Irié, J. Tanaka, T. Atsumi, M. Murakami, M. Nakayama, O. Ohara, S. Himeno, H. Yoshida, H. Koseki, T. Ikawa, K. Mishima, and T. Fukada. Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength. Proc Natl Acad Sci USA 12;111(32):11786-91, 2014 (PubMed)
112.
Atsumi, T., R. Singh, L. Sabharwal, H. Bando, J. Meng, Y. Arima, M. Yamada, M. Harada, J-J Jiang, D. Kamimura, H. Ogura, T. Hirano, and M. Murakami. Inflammation amplifier, a new paradigm in cancer biology. Cancer Research 74(1): 8-14, 2014 (PubMed) (Review)
111.
Ogura, H., T. Atsumi, H. Bando, L. Sabharwal, M. Yamada, J.-J. Jiang, A. Nakamura, Y. Arima, D. Kamimura, and M. Murakami. The reverse-direction method links mass experimental data to human diseases. Archivum Immunologiae et Therapiae Experimentalis 62(1): 41-45, 2014 (PubMed) (Review)
110.
Mori, Y*, M. Murakami#,*, Y. Arima*, D. Zhu, Y. Terayama, Y. Komai, Y. Nakatsuji, D. Kamimura, and Y. Yoshioka (*, equal contribution; #, correspondence) Early pathological alterations of lower lumber cords detected by ultra-high field MRI in a mouse multiple sclerosis model. Int Immunol. 26(2): 93-101, 2014 (PubMed)

2013

109.
Kamimura, D., M Yamada, M Harada, L. Sabharwal, J Meng, H Bando, H Ogura, T Atsumi, Y Arima, M Murakami. The gateway theory: bridging neural and immune interactions in the CNS. Front. Neurosci. doi: 10.3389/fnins.2013.00204 (PubMed)(Review)
108.
Singh, R., T Atsumi, H Bando, M Harada, A Nakamura, M Yamada, J-J Jiang, H Suzuki, K Katsunuma, T Nodomi, D Kamimura, H Ogura, M Murakami. Reverse direction method: A possible tool to link animal models with corresponding human diseases and disorders. Int. J. Genomic Med. 1:106. doi: 10.4172/ijgm.1000106, 2013 (Int J Genomic Med) (Review)
107.
Kamimura, D., M Yamada, L Sabharwal, H Ogura, Y Okuyama, A Nakamura, T Atsumi, Y Arima, M Murakami. The Gate Theory Explains Regional Neural Regulation of Activated T cells Entering the Central Nervous System. Journal of Clinical & Cellular Immunology 4:156 doi: 10.4172/2155-9899.1000156. (J Clin Cell Immunol) (Review)
106.
Murakami M*#, M Harada*, D Kamimura*, H Ogura, Y Okuyama, N Kumai, A Okuyama, R Singh, J Jiang, T Atsumi, S Shiraya, Y Nakatsuji, M Kinoshita, H Kohsaka, M Nishida, S Sakoda, N Miyasaka, K Yamauchi-Takihara, T Hirano# (*, equal contribution; #, correspondence) Disease-Association Analysis of an Inflammation-Related Feedback Loop. Cell Reports. 3: 946-959, 2013 (PubMed)
105.
Sasaki M, A Tojo, Y Okochi, N Miyawaki, D Kamimura, A Yamaguchi, M Murakami, Y Okamura. Autoimmune disorder phenotype in HVCN1 gene deficient mice. Biochem. J. 450: 295-301, 2013 (PubMed)
104.
Lee J*, T Nakagiri*, D Kamimura*, M Harada, T Oto, Y Susaki, Y Shintani, M Inoue, S Miyoshi, E Morii, T Hirano, M Murakami#, M Okumura. (*, equal contribution; #, correspondence) IL-6 amplifier activation in epithelial regions of bronchi after allogeneic lung transplantation. Int Immunol. 25: 319-332, 2013 (PubMed)
103.
Kusu T, H Kayama, M Kinoshita, S Gyu-Jeon, Y Ueda, Y Goto, R Okumura, H Saiga, T Kurakawa, K Ikeda, Y Maeda, J Nishimura, Y Arima, K Atarashi, K Honda, M Murakami, J Kunisawa, H Kiyono, M Okumura, M Yamamoto, K Takeda. Ecto-Nucleoside Triphosphate Diphosphohydrolase 7 Controls Th17 Cell Responses through Regulation of Luminal ATP in the Small Intestine. J Immunol. 190: 774-783, 2013 (PubMed)
102.
Arima Y, D. Kamimura, L. Sabharwal, M. Yamada, H. Bando, H. Ogura, T. Atsumi and M Murakami. Regulation of Immune Cell Infiltration into the CNS by Regional Neural Inputs Explained by the Gate Theory. Mediators of Inflammation. vol. 2013, Article ID 898165, 8 pages, 2013. doi:10.1155/2013/898165 (Mediators Inflamm.) (Review)
101.
Ogura H, Y. Arima, D. Kamimura, and M Murakami# (#, correspondence) The Gate Theory: How Regional Neural Activation Creates a Gateway for Immune Cells via an Inflammation Amplifier. Biomedical J. 36(6): 269-273, 2013 (PubMed) (Review)

2012

100.
Lee J, T Nakagiri, T Oto, M Harada, E Morii, Y Shintani, M Inoue, Y Iwakura, S Miyoshi, M Okumura, T Hirano, M Murakami#. IL-6 Amplifier, NF-κB-Triggered Positive Feedback for IL-6 Signaling, in Grafts Is Involved in Allogeneic Rejection Responses. (#, correspondence) J Immunol. 189: 1928-1936, 2012 (PubMed) (MDLinks)
99.
Kayama H, Y Ueda, Y Sawa, SG Jeon, JS Ma, R Okumura, A Kubo, M Ishii, T Okazaki, M Murakami, M Yamamoto, H Yagita, K Takeda. Intestinal CX3C chemokine receptor 1high (CX3CR1high) myeloid cells prevent T-cell-dependent colitis. Proc. Natl. Acad. Sci. USA. 109: 5010-5015, 2012 (PubMed)
98.
Arima Y, M Harada, D Kamimura, J Park, F Kawano, FE Yull, T Kawamoto, Y Iwakura, UAK Betz, G Márquez, T S Blackwell, Y Ohira, T Hirano, M Murakami#. Regional Neural Activation Defines a Gateway for Autoreactive T Cells to Cross the Blood-Brain Barrier. (#, correspondence) Cell. 148: 447-457, 2012 (PubMed) (Cell Previews) (Research Highlight in Nature Reviews of Neuroscience) (Pain Research Forum) (Global Medical Discovery)
97.
Murakami M#, T Hirano. (#, correspondence) The Molecular Mechanisms of Chronic Inflammation Development Front. Immunol. 07 October 2012 | doi: 10.3389/fimmu.2012.00323 (Front. Immunol.) (Review)
96.
Murakami M#, T Hirano. The pathological and physiological roles of IL-6 amplifier activation. (#, correspondence) Int. J. Biol. Sci. 8: 1267-1280. 2012 (PubMed) (Review)

2011

95.
Verjan Garcia N, E Umemoto, Y Saito , M Yamasaki, E Hata, T Matozaki, M Murakami, YJ Jung, SY Woo, JY Seoh, MH Jang, K Aozasa, M Miyasaka. SIRPalpha/CD172a Regulates Eosinophil Homeostasis. J. Immunol. 187: 2268-2277, 2011 (PubMed)
94.
Murakami M*, Y Okuyama*, H Ogura*, S Asano, Y Arima, M Tsuruoka, M Harada, M Kanamoto, Y Sawa, Y Iwakura, K Takatsu, D Kamimura, T Hirano. (*equal contribution) Local microbleeding facilitates IL-6– and IL-17–dependent arthritis in the absence of tissue antigen recognition by activated T cells. J. Exp. Med. 208: 103-114, 2011 (PubMed) (Research Highlight in Nature Review Immunology)
93.
Nishida K., T Fukada, S Yamasaki, M Murakami, T Hirano. Zinc in Allergy, Autoimmune, and Hard and Connective Tissue Diseases. in Zinc in Human Health edited by L. Rink., IOS Press, 268-282, 2011. (Review)
92.
Fukada, T, K Nishida, S Yamazaki, M Murakami, T Hirano. Zinc homeostasis and signaling in health and diseases: Zinc signaling. J Biol Inorg Chem.16:1123-1134, 2011 (PubMed) (Review)
91.
Murakami M, T Hirano. A four step model for the IL-6 amplifier, a regulator of chromic inflammations in tissue specific MHC class II-associated autoimmune diseases. Front. Immun. 2:22. doi: 10.3389/fimmu.2011.00022 (Front. Immun,) (Review)

2010

90.
Kitabayashi C, T. Fukada M Kanamoto, W Ohashi, S Hojyo, T Atsumi, N Ueda, I Azuma, H Hirota, M Murakami, T Hirano. Zinc suppresses Th17 development via inhibition of STAT3 activation. Int. Immunol. 22: 375-386, 2010 (PubMed) (Editor's choice: featured articles)
89.
Nakagawa T*, M Tsuruoka*, H Ogura, Y Okuyama, Y Arima, T Hirano, M Murakami#. (*equal contribution; #, correspondence) IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int. Immunol. 22(2):129-139, 2010 (PubMed) (Editor's choice: featured articles)

2009

88.
Sawa Y, Y Arima, H Ogura, C Kitabayashi, J Jiang, T Fukushima, D Kamimura, T Hirano, M Murakami#. (#, correspondence) Hepatic Interleukin-7 Expression Regulates T Cell Responses. Immunity 30: 447-457, 2009 (PubMed) (Immunity Preview) (Comment in Science-Buisiness eXchange)
87.
Atsumi T*, M Sato*, D Kamimura, A Moroi, Y Iwakura, UAK Betz, A Yoshimura, M Nishihara, T Hirano, M Murakami#. (*equal contribution; #, correspondence) IFN-γ expression in CD8+ T cells regulated by IL-6 signal is involved in superantigen-mediated CD4+ T cell death. Int. Immunol. 21: 73-80, 2009 (PubMed)

2008

86.
Ogura H*, M Murakami*, Y Okuyama, M Tsuruoka, C Kitabayashi, M Kanamoto, M Nishihara, Y Iwakura T Hirano. (*equal contribution) Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction. Immunity, 29: 628-636, 2008. (PubMed)
85.
Jin G, T Hirano, M Murakami#. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation. (#, correspondence) Int. Immunol. 20: 783-789, 2008. (PubMed)
84.
Tanaka Y, N Tanaka, Y Saeki, K Tanaka, M Murakami, T Hirano, N Ishii, K Sugamura. c-Cbl-dependent Monoubiquitination and Lysosomal Degradation of gp130. Mol. Cell. Biol.  28: 4805-4818, 2008.(PubMed)
83.
Murakami M, Hirano T. Intracellular Zinc homeostasis and Zinc signaling. Cancer Science 99: 1515-22, 2008.(PubMed) (Review)
82.
Hirano T, M Murakami, T Fukada, K Nishida, S Yamasaki, T Suzuki. Roles of Zinc and Zinc signaling in immunity: Zinc is an intracellular signaling molecule. Advances in Immunology. 97: 149-176, 2008. (PubMed)(Review)

2007

81.
*Nishihara M, *H Ogura, N Ueda, M Tsuruoka, C Kitabayashi, F Tuji, H Aono, K Ishihara, E Huseby, UAK Betz, M Murakami, T Hirano. (*equal contribution) IL-6-gp130-STAT3 in T cells directs the development of IL-17+T helper cells with a minimum effect on that of Treg in the steady state. Int. Immunol. 19: 695-702,2007. (PubMed)
80.
*Khiong K, *M Murakami#, C Kitabayashi, N Ueda, S Sawa, A Sakamoto, BL Kotzin, SJ. Rozzo, K Ishihara, M Verella-Garcia, J Kappler, P Marrack, T Hirano. (*equal contribution; #, correspondence). Homeostatic proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J. Clin. Invest. 117: 1270-1281, 2007(PubMed) (Full text of JCI) (Commentary in JCI) (Research Highlights in Nature Immunology) (Research Highlight in Nature Reviews Immunology)

2006

79.
Kamon H, T Kawabe, H Kitamura, D Kamimura, G Jin, T Kaisyo, S Akira, A Iwamatsu, H Koga, K Ishihara, M Murakami, T Hirano. TRIF-GEFH1-RhoB cascade regulates surface expression of MHC class II in dendritic cells that is critical for CD4+ T cell activation. EMBO J. 25: 4108-4119, 2006. Epub 2006 Aug 17 (PubMed)
78.
Ueda N, H Kuki, D Kamimura, S Sawa, K Seino, M Taniguchi, T Hirano, M Murakami#. (#, correspondence) CD1d-restricted natural killer T cell activation enhanced homeostatic proliferation of CD8+T cells in a manner dependent on IL-4. Int. Immunol.18: 1397-1404, 2006. Epub 2006 Aug 16 (PubMed)
77.
Kitamura H, H Morikawa, H Kamon, M Iguchi, S Hojyo, T Fukada, S Yamashita, T Kaisho, S Akira, M Murakami T Hirano. Toll-like receptor-mediated regulation of zinc homeostasis influences dendritic cell function. Nat. Immunol.7: 971-977, 2006 (PubMed) (Research Highlights in Nature) (RIKEN RESEARCH) (Spotlight of ACS Chemical Biology)
76.
Kamimura D, Y Sawa, M Sato, E Agung, T Hirano, M Murakami#. (#, correspondence) IL-2 in vivo activities and anti-tumor efficacy enhanced by an anti-IL-2 mAb. J. Immunol. 177: 306-314, 2006 (PubMed)
75.
Sawa S, D Kamimura, G Jin, H Morikawa, H Kamon, M Nishihara, K Ishihara, M Murakami, T Hirano. Autoimmune arthritis associated with mutated IL-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J. Exp. Med. 203: 1459-1470, 2006. published on line 22 May 2006, 10.1084/jem.20052187.(PubMed) (J Exp Med) (In This Issue of JEM) (Research Highlights in Nature Reviews Immunology )
74.
Hirano T, M. Murakami. Grasp a pTyr-peptide by its SOCS. Dev. Cell 10: 542-544, 2006 (PubMed) (Review)

2005

73.
Kitamura, H., H. Kamon, S. Sawa, S-J. Park, N. Katsunuma, K. Ishihara, M. Murakami and T. Hirano. IL-6-STAT3 controls intracellular MHC classII ab-dimer level through Cathepsin S activity in dendritic cells. Immunity, 23: 491-502, 2005. (PubMed). (Immunity) (Science's STKE) (Research Highlights in Nature Immunology)

2004

72.
Kamimura D, Ueda N, Hachida S, Atsumi T, Nakagawa T, Sawa S, Suzuki H, Ishihara K, Murakami M, Hirano T. Evidence of a novel IL-2/15Rbeta-targeted cytokine involved in homeostatic proliferation of memory CD8+ T cells. J. Immunol. 173: 6041-6049, 2004. (PubMed).
71.
Park S, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T. IL-6 Regulates in vivo Dendritic Cell Differentiation through STAT3 Activation. J. Immunol. 173:3844-3854, 2004. (PubMed)
70.
Ishihara K, Sawa S, Ikushima H, Hirota S, Astumi T, Kamimura D, Park S, Murakami M, Kitamura Y, Iwakura Y, Hirano T. The point mutation of Y759 of the IL-6 family receptor gp130 synergizes with HTLV-1 pX in promoting RA-like arthritis. Int. Immunol. 16: 455-465, 2004. (PubMed) (Int. Immunol)
69.
Murakami M, Kamimura D, Hirano T. New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27. Growth Facotrs 22: 75-77, 2004. (Review)

2003

68.
Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nature Immunology, 4: 551-556, 2003. (PubMed).

Before 2003

67.
Yamashita K, Masunaga T, Yanagida N, Takehara M, Hashimoto T, Kobayashi T, Echizenya H, Hua N, Fujita M, Murakami M, Furukawa H, Uede T, Todo S. Long-term acceptance of rat cardiac allografts on the basis of adenovirus mediated CD40Ig plus CTLA4Ig gene therapies. Transplantation 15;76:1089-96. 2003.
66.
Tosa N, Murakami M, Jia WY, Yokoyama M, Masunaga T, Iwabuchi C, Inobe M, Iwabuchi K, Miyazaki T, Onoe K, Iwata M, Uede T. Critical function of T cell death-associated gene 8 in glucocorticoid-induced thymocyte apoptosis. Int Immunol. 15, 741-749, 2003.
65.
Kanaya K, Tsuchida Y, Inobe M, Murakami M, Hirose T, Kon S, Kawaguchi S, Wada T, Yamashita T, Ishii S, Uede T. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation 75, 275-81, 2003.
64.
Nagamori M, Kawaguchi S, Murakami M, Wada T, Nagoya S, Yamashita T, Inobe M, Uede T. Intrinsic and extrinsic manipulation of B7/CTLA-4 interaction for induction of anti-tumor immunity against osteosarcoma cells. Anticancer Res. 22, 3223-3227, 2002.
63.
Nagamori M, Kawaguchi S, Murakami M, Wada T, Inobe M, Ishii S, Uede T. In vivo immunogenicity of osteosarcoma cells that express B7-1a, an alternatively spliced form of B7-1. Anticancer Res. 22, 2009-13, 2002.
62.
Swanson BJ, Murakami M, Mitchell1 TC, Kappler J, Marrack P. RANTES production by memory phenotype T cells is controlled by a posttranscriptional, TCR dependent process. Immunity 17, 5, 605-615. 2002.
61.
Murakmi M, Sakamoto A, Bender J, Kappler J, Marrack P. CD25+CD4+ T cells contribute to the control of memory CD8+ T cells. Proc. Natl. Acad. Sci. U.S.A. 99, 8832-8837, 2002.
60.
Nomura M, Yamashita K, Murakami M, Takehara M, Echizenya H, Sunahara M, Kitagawa N, Fujita M, Furukawa H, Uede T, Todo S. Induction of donor-specific tolerance by adenovirus mediated CD40Ig gene therapy in rat liver transplantation. Transplantation 74, 1403-1410, 2002.
59.
Konishi K, Inobe M, Yamada A, Murakami M, Todo S, Uede T. Combination treatment with FTY720 and CTLA4IgG preserves the respiratory epithelium and prevents obliterative desease in a murine airway model. J Heart Lung Transplant. 21, 692-700, 2002.
58.
Iwasaki N, Gohda T, Yoshioka C, Murakami M, Inobe M, Minami A, Uede T. Feasibility of immunosuppression in composite tissue allografts. Transplantation 73, 334-40, 2002.
57.
Chiba S, Okamoto H, Kon S, Kimura C, Murakami M, Inobe M, Matsui Y, Sugawara T, Shimizu T, Uede T, Kitabatake A. Development of atherosclerosis in osteopontin transgenic mice. Heart and vesseles. 16,111-117, 2002.
56.
Ijima K, Murakami M, Okamoto H, Inobe M, Chikuma S, Saito I, Kanegae Y, Kawaguchi Y, Kitabatake A, Uede T. Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis. Human Gene Therapy 12, 1063-77, 2001.
55.
Ueno H, Murakami M, Okumura M, Kadosawa T, Uede T, and Fujinaga T. Chitosan accelerates the production of osteopontin from polymorphonuclear leukocytes. Biomaterials 22, 1667-73, 2001.
54.
Takehara M, Murakami M, Nakagawa I, Saito I, Kanegae Y, Nomura M, Ohmura T, Todo S, Uede T. Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4Ig. Human Gene Therapy 12, 415-426, 2001.
53.
Nomura M, Yamashita K, Murakami M, Takehara M, Konishi M, Echizenya H, Yanagida N, Sunahara M, Kitagawa N, Furukawa H, Uede T, Todo S. Novel CD40-IgG adenovirus-mediated gene therapy as a potent immunosuppressive treatment for liver transplantation in rats. Transplant. Proc. 33, 189, 2001.
52.
Yanagida N, Nomura M, Yamashita K, Takehara M, Murakami M, Echizenya H, Konishi K, Kitagawa N, Furukawa H, Uede T, Todo S. Tolerance induction by a single donor pretreatment with the adenovirus vector encoding CTLA4Ig gene in rat orthotopic liver transplantation. Transplant. Proc. 33, 573-574, 2001.
51.
*Ku CC, *Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288, 675-678, 2000. (*equal contribution)
50.
Marrack P, Bender J, Hildeman D, Jordan M, Mitchell T, Murakami M, Sakamoto A, Schaefer BC, Swanson B, Kappler J. Homeostasis of alpha and beta TCR+ T cells. Nature Immunol. 2, 107-111, 2000. (Review)
49.
Chikuma S, Murakami M, Tanaka K, Uede T. Janus Kinase 2 is associated with box 1-like motif and phosphrylates a critical tyrosine residue in the cytoplasmic region of CTLA-4. J. Cell. Biochem. 78, 241-250, 2000.
48.
Chiba S, Rashid MM, Okamoto H, Shiraiwa H, Kon S, Maeda M, Murakami M, Inobe M, Kitabatake A, Chambers AF, Uede T. The role of osteopontin in the development of granulomatous lesions in lung. Microbiol. Immunol. 44, 319-332, 2000.
47.
Takiguchi M, Murakami M, Nakagawa I, Rashid MM, Tosa N, Chikuma S, Hashimoto A, Uede T. Involvement CD28/CTLA4-B7 costimulatory pathway in the development of lymphadenopathy and splenomegary in MRL/lpr mice. J. Vet. Med. Sci. 62, 29-36, 2000.
46.
Yamada A, Konishi K, Crus GL, Takehara M, Morikawa M, Nakagawa I, Murakami M, Abe T, Todo S, Uede T. Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 69, 743-749, 2000.
45.
Harada H, Ishikura H, Nakagawa I, Shindou J, Murakami M, Uede T, Koyanagi I, Yoshiki T. Donor-specific prolongation of survival of rat renal allografts by preoperative inoculation of CTLA4Ig plus allogeneic dendritic cells. Urol. Res. 28, 69-74, 2000.
44.
Yamashita K, Nomura M, Omura T, Takehara M, Suzuki T, Shimamura T, Kishida A, Furukawa H, Murakami M, Uede T, Todo S. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats. Transplant. Proc. 31, 1178-1179, 1999.
43.
Takiguchi M, Murakami M, Nakagawa I, Yamada A, Chikuma S, Kawaguchi Y, Hashimoto A, Uede T. Blockade of CD28/CTLA4-B7 costimulatory pathway prevented autoantibody-related diseases but not lung diseases in MRL/lpr mice. Life Science 79, 317-326, 1999.
42.
Sato J, Asakura K, Murakami M, Uede T, Kataura A. Topical CTLA4Ig suppresses ongoing mucosal immune response in presensitized murine model of allergic rhinitis. Int. Aarch. Allergy Immunol. 119, 197-200, 1999.
41.
Takiguchi M, Murakami M, Nakagawa I, Yamada A, Chikuma S, Hashimoto A, Uede T. Blockade of CD28/CTLA4-B7 pathway prevented lymphadenopacy in MRL/lpr mice. Laboratory Investigation 79, 317-326, 1999.
40.
Tarumi K, Murakami M, Yagihashi A, Nakagawa I, Hirata K, Uede T. CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. Transplantation 67, 520-525, 1999.
39.
Katagiri Y, Sleeman, T, Fujii H, Herlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers A, Uede T. CD44 variants but not CD44s cooperate with b1-containing integrins to permit cells to bind to osteopontin independently of RGD, there by stimulating cell motility and chemotaxis. Cancer Res. 59, 219-226, 1999.
38.
Aoki N, Inobe M, Murakami M, Abe R, Iizuka H. The functional role of B7 molecules on the induction of thymocyte activation and apoptosis. Microbiol. Immunol. 42, 5555-5565, 1998.
37.
Isashi Y, Yamashita T, Nagasawa S, Tanaka K, Murakami M, Uede T. The mechanism by which proteolysis enhances the ligand-binding activity of guinea pig type II Fc receptor for IgG (FcgRII). J. Biochem. 123, 959-967, 1998.
36.
Fujii H, Inobe M, Hayakawa Y, Kimura F, Murakami M, Ohnishi Y, Azuma I, Uede T, Saiki I. Vaccination with B7-1+ tumor and antiadhesion therapy with RGD pseudo-peptide (FC-336) efficiently induce anti-metastatic effect. Clin. Exp. Metastasis 16, 141-148, 1998.
35.
Tarumi K, Yagihashi A, Murakami M, Uede T. Hirata K. Prolongation of rat small bowel allograft survival by CTLA4Ig. Transplant. Proc. 30, 2596-2599, 1998.
34.
Iizuka J, Katagiri Y, Tada N, Murakami M, Ikeda T, Sato M, Hirokawa K, Okada S, Hatano M, Tokuhisa T, Uede T. Introduction of an osteopontin gene confers the increase in B1 cell population and the production of anti-DNA autoantibodies. Laboratory Investigation 78, 1523-1533.
33.
Nakagawa I, Murakami M, Ijima K, Chikuma S, Saito I, Kanegae Y, Ishikura H Yoshiki T, Okamoto H, Kitabatake A, Uede T. Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG. Human Gene Therapy 9, 1739-1745, 1998.
32.
Hakamida-Taguchi R, Kato T, Ushijima H, Murakami M, Uede T, Nariuchi H. Expression and co-stimulatory function of B7-2 on murine CD4+ T cells. Eur. J. Immunol. 28, 865-873, 1998.
31.
Fukumoto T, Torigoe N, Kawabata S, Murakami M, Uede T, Nishi T, Ito Y, Sugimura K. Peptide mimics of the CTLA4-binding domain stimulate T-cell proliferation. Nature Biothechnology 16, 267-270, 1998.
30.
Kaneda R, Iwabuchi K, Kasai M, Murakami, M, Uede T, Onoe K. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molceules and in efficient presentation of MHC-peptide ligands. Cell.Immunol. 181, 163-171, 1997.
29.
Uede T, Katagiri Y, Iizuka J, Murakami M. Osteopontin, a cordinator of host defense system: a cytokine or an extracellular adhesive protein? Microbiol. Immunol. 41, 641-648, 1997. (Review)
28.
Tsuchida T, Usui M, Murakami M, Uede T. Vascularized bone marrow allotransplantation in rats prolong the survival of simultaneously grafted alloskin, Transplantation Proc. 29, 1732-1733, 1997.
27.
Tsuchida T, Naitoh T, Takahashi T, Usui M, Murakami M, Uede T. Limb allografts in rats treated with anti-ICAM1 and anti-LFA1 monoclonal antibodies. J. Recconst. Microsurg. 13, 107-110, 1997.
26.
Hara T, Murakami M, Maeda H, Hibi M, Uede T. Involvement of common 10 amino acid segment in the cytoplasmic region of CD40 but different MAP kinases in different CD40-mediated responses. Biochem. Biophys. Res. Commun. 233, 187-192, 1997.
25.
Hayakawa M, Kwaguchi S, Ishii S, Murakami M, Uede T. B7-1-transfected tumor vaccine counteracts chemoterapy-induced immunosuppression and prolongs the survival of rats bearing highly metastatic osteosarcoma cells. Int. J. Cancer 72, 1-12, 1997.
24.
Murakami M, Takahashi Y, Isashi Y, Kon S, Inobe M, Abe R. Uede T. Identification and characterization of an alternative CTLA4 binding molecule on B cells. Proc. Natl. Acad. Sci., U.S.A. 93, 7838-7842, 1996.
23.
Yamada A, Murakami M, Ijima K, Yagita H, Okumura K, Komatsu S, Uede T. Long-term acceptance of major histocompatibility complex-mismached cardiac allograft induced by a low dose of CTLA4IgM plus FK506. Microbiol. Immunol. 40, 513-518, 1996.
22.
Isashi Y, Yamashita T, Nagasawa S, Murakami M, Uede T. Molecular cloning and characterization of gunia-pig FcgRIII: expression but not function is independent of the g chain of FceRI. Int. Immunol. 8, 1335-1346, 1996.
21.
Katagiri Y, Murakami M, Mori K, Iizuka J, Hara T, Tanaka K, Jia WY, Chambers AF, Uede T. Non-RGD domains of osteopontin promote cell adhesion without involving aV integrins. J. Cell Biochem. 62, 123-131, 1996.
20.
Inobe M, Aoki N, Linsley PS, Ledbetter JA, Murakami M, Uede, T. The role of B7-1a molecule, an alternatively spliced form of murine B7-1, on T cell activation. J. Immunol. 157, 582-588, 1996.
19.
Fujii H, Inobe M, Kimura F, Murata J, Murakami M, Onishi Y, Azuma I, Uede T, Saiki I. Vaccination of tumor cells transfected with B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice. Int. J. Cancer 66, 219-224, 1996.
18.
Toyooka K, Maruo S, Iwahori T, Yamamoto N, Tai XG, Abe R, Takahama Y, Murakami M, Uede T, Hamaoka T Fujiwara H. CD28 costimulatory signals induce IL-2 receptor expression on antigen stimulated virgin T cells by an IL-2-independent mechanisms. Int. Immunol. 8, 159-169, 1995.
17.
Isashi Y, Tamakoshi M, Nagai Y, Sudo T, Murakami M, Uede T. The rat neutrophil low affinity Fc receptor for IgG: Moleculare cloning and functional characterization. Immunology letters 46, 157-163, 1995.
16.
Yoneya K, Okamoto H, Machida M, Onozuka H, Noguchi M, Mikami T, Kawaguchi H, Murakami M, Uede T, Kitabatake A. Angiotensin-converting enzyme gene polymorphism in japanese patients with hypertrophic cardiomypathy. American Heart J. 130, 1089-1093, 1995.
15.
Kamikubo Y, Murakami M, Imamura M, Murashita T, Yasuda K, Uede T. Neutrophil-independent myocardial dysfunction during an early stage of global ischemia and repurfusion of isolated hearts. Immunopharmacology 29, 261-271, 1995.
14.
Katagiri Y, Mori K, Hara T, Tanaka K, Murakami M, Uede T. Functional analysis of osteopontin molecule. Ann. N. Y. Acad. Sci. 760, 371-374, 1995.
13.
Murakami M, Hibi M, Nakagawa T, Yasukawa K, Yamanishi K, Taga T, Kishimoto T. IL-6 induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 160, 1808-1810, 1993.
12.
Yawata H, Yasukawa K, Nastuka S, Murakami M, Yamasaki H, Hibi M, Taga T Kishimoto T. Structure-function analysis of human IL-6 receptor: disscciation of amino acid residues required for IL-6 binding and for IL-6 siganl transduction through gp130. EMBO J. 12, 1705-1712, 1993.
11.
Kishimoto T, Hibi M, Murakami M, Narazaki M, Saito M Taga T. The molecular bioloby of interleukin 6 and its receptor. In Polyfunctional cytokines: IL-6 an LIF, edt. by Gregory R. Bock, Joan Marsh (Organizers) and Kate Widdows, John Wiley & Sons, Chichester. p.5-23, 1992. (Review)
10.
Falus A, Hibi M, Murakami M, Taga T Kishimoto T. Regulation of IL-6 receptor and gp130 expression on human cell lines of lymphoid myeloid origin. Cytokine 4, 495-499, 1992.
9.
Taga T, Hibi M, Murakami M, Saito M, Yawata H, Narazaki M, Hirata Y, Sugita T, Yasukawa K, Hirano T, Kishimoto T. Interleukin 6 receptor and signals. Chem. Immunol. 51:181-204, 1992. (Review)
8.
Liu J, Modrell B, Aruffo A, Marken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T. Shoyab M. Interleukin-6 signal transducer gp130 mediates Oncostatin M signaling. J. Biol. Chem. 267, 16763-16766, 1992.
7.
Kishimoto T, Hibi M, Murakami M, Narazaki M, Saito M, Taga T. The molecular biology of interleukin 6 and its receptor. Chiba-Found-Symp. 167, 5-23, 1992. (Review)
6.
Taga T, Hibi M, Murakami M, Saito M, Yawata H, Narazaki M, Hirata Y, Sugita T, Yasukawa K, Hirano T, Kishimoto T. IL-6 receptor and signals. In Chemical Immunology: Interleukins: MolecularBiology and Immunology, ed. by Kishimoto, T., and S. Karger AG, Basel Switzerland. vol. 51, p181-204, 1992. (Review)
5.
Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, Taga T. Kishimoto T. Critical cytoplasmic region of the IL-6 signal transducer, gp130, is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. U.S.A. 88, 11349-11353, 1991
4.
Taga T, Hibi M, Murakami M, Saito M, Hirano T Kishimoto, T. A new cytokine receptor family ans a novel signaling mechanism by receptor-associate IL-6 signal transducer, gp130. In Origins Human Cancer: A comprehensive Review. Cold Spring Harver Lab. Press, NY, USA. 277-284, 1991. (Review)
3.
Hibi M, Murakami M, Saito M, Hirano T, Taga T Kishimoto T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157, 1990.
2.
Hirano T, Taga T, Matsuda T, Hibi M, Suematsu S, Tang B, Murakami M, Kishimoto T. Interleukin 6 and its receptor in the immune response and hematopoiesis. Int. J. Cell Cloning 8:155-167, 1990. (Review)
1.
Suematsu S, Hibi M, Sugita T, Saito M, Murakami M, Matsusaka T, Matsuda T, Hirano T, Taga T, Kishimoto T. Interleukin 6 (IL-6) and its receptor (IL-6R) in myeloma/plasmacytoma. In Current topics in microbiology and immunology Vol. 166, edt. by M. Potter and F. Melchers, Springer-Verlag Berlin Heidelberg. p.13-22, 1990. (Review)

Copyright © 2015 Hokkaido UNIVERSITY all rights reserved.
Page Top